Given these results and previous reports that eIF2α phosphorylation is upregulated in the neoplastic cells of melanoma, colon cancer, Hodgkin’s lymphoma, and TNBC [37], PKR-mediated eIF2α phosphorylation can potentially serve as a marker for TNBC. Here, EIF2AK2 is linked to Hodgkins lymphoma.